SAGILITY LIMITED

SAGILITY LIMITED

Sagility Limited has informed the Exchange regarding the re-appointment of Mr. Hari Gopalakrishnan as a Non-Executive Non-Independent Director, retiring by rotation, at the 5th Annual General Meeting.

SAGILITY LIMITED

Sagility Limited has submitted the Scrutinizer's report of its 5th Annual General Meeting, which was held on August 20, 2026, and has informed the Exchange regarding voting results.

SAGILITY LIMITED

Sagility Limited held its 5th Annual General Meeting (AGM) on August 20, 2026, through video conferencing. The meeting was attended by all directors and key managerial personnel. The AGM transacted the adoption of audited financial statements for the year ended March 31, 2026, and other ordinary business.

SAGILITY LIMITED

Sagility Limited has informed the Exchange about the schedule of an investor conference, where company officials will discuss industry and company-specific developments already in the public domain.

SAGILITY LIMITED

Sagility Limited has informed the Exchange regarding 'Dispatch of Letter to shareholders on Annual Report FY2025-26'. The company has sent a letter to shareholders who have not registered their email addresses, providing a web-link to the Notice of the 5th Annual General Meeting and the Annual Report for the Financial Year 2025-26.

SAGILITY LIMITED

Sagility Limited has informed the Exchange about a copy of newspaper publication regarding the 5th Annual General Meeting of the Company to be held through Video Conferencing and details relating to e-voting facility. The details are also being made available on the Company's website.

SAGILITY LIMITED

Sagility Limited held an earnings call on July 21, 2026, to discuss its unaudited financial results for the quarter ended June 30, 2026. The company reported a strong start to FY 2027, with growth driven by expansion within existing client relationships and the addition of new clients. The management highlighted the company's healthcare-focused operating model, client relationships, and disciplined execution across geographies. The company also discussed its strategic priorities, including moving beyond fragmented process-led models towards integrated, outcome-driven operating frameworks, and increasing its capabilities in the healthcare value chain.

SAGILITY LIMITED

Sagility Limited has informed the Exchange about the schedule of investor meetings to be held on July 30th and 31st, 2026, in Mumbai. The company officials will reiterate industry and company-specific developments already in the public domain, and no unpublished price-sensitive information will be shared during these sessions.

SAGILITY LIMITED

Sagility Limited has informed the Exchange about a scheduled investor meeting on July 30-31, 2026, in Mumbai, where the company officials will discuss industry and company-specific developments already in the public domain, without sharing any unpublished price-sensitive information.

SAGILITY LIMITED

Sagility Limited has submitted its Business Responsibility and Sustainability Report for FY 2025-26, along with a Reasonable Assurance Report provided by DNV Business Assurance India Private Limited. The report is available on the company's website.

SAGILITY LIMITED

Sagility Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 20, 2026, through video conferencing. The meeting will consider and pass various resolutions, including the audited financial statements, appointment of a director, and declaration of dividends.

SAGILITY LIMITED

Sagility Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, regarding the Reconciliation of Share Capital Audit for the quarter ended June 30, 2026.

SAGILITY LIMITED

Sagility Limited has informed the Exchange about Copy of Newspaper Publication relating to the unaudited financial results for the quarter ended June 30, 2026

SAGILITY LIMITED

Sagility Limited has informed the Exchange about Copy of Newspaper Publication regarding 5th Annual General Meeting (AGM) of the Company, prior to dispatch of the AGM Notice and Annual Report FY2025-26.

SAGILITY LIMITED

Sagility Limited has informed the National Stock Exchange about the link of recording for an investor/analyst webinar held on July 21, 2026, to discuss the unaudited financial results for the quarter ended June 30, 2026. The recording is available on the company's website.

SAGILITY LIMITED

Sagility Limited has informed the Exchange about the re-appointment of Internal Auditor, PricewaterhouseCoopers Services LLP, from October 01, 2026, to March 31, 2028.

SAGILITY LIMITED

Sagility Limited reported its unaudited financial results for the quarter ended June 30, 2026, with revenue growth of 27.6% YoY, adjusted EBITDA at 24.0%, and adjusted PAT at 13.7%. The company secured $35.3 million of steady-state ACV and added 27 clients in Q1 FY27.

SAGILITY LIMITED

Sagility Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results and a Limited Review Report submitted by the Statutory Auditors.

SAGILITY LIMITED

Sagility Limited has submitted an investor presentation for Q1 FY27, highlighting 27.3% YoY revenue growth, driven by expansion within existing clients and new client wins, and acquired CareSeed to strengthen its position in healthcare quality.

SAGILITY LIMITED

Sagility Limited has informed the Exchange regarding Outcome of Board Meeting held on July 21, 2026. The Board of Directors have considered and approved the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026, and re-appointed PricewaterhouseCoopers Services LLP as Internal Auditors of the Company.